NCT05389423 2026-02-19Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting25 enrolled
NCT04068597 2025-12-18Study to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesCellCentric Ltd.Phase 1/2 Recruiting250 enrolled